MdmX is a RING finger ubiquitin ligase capable of synergistically enhancing Mdm2 ubiquitination
- PMID: 12393902
- DOI: 10.1074/jbc.M208593200
MdmX is a RING finger ubiquitin ligase capable of synergistically enhancing Mdm2 ubiquitination
Abstract
It has been well documented that Mdm2 and its homologue MdmX not only are critical negative regulators of the tumor suppressor p53 but that both Mdm2 and MdmX interact to affect the function of the other. The mechanisms through which these effects are manifested, however, remain unclear. Although Mdm2 has been established as a RING finger ubiquitin ligase, MdmX has not been shown to possess this activity despite the extensive sequence homology between their respective RING finger domains. Here we demonstrate that MdmX acts as a ubiquitin ligase in vitro, being capable of autoubiquitination, as well as mediating the ubiquitination of p53. The addition of Mdm2 to in vitro ubiquitination assays containing MdmX results in a synergistic increase of ubiquitin conjugation. Analysis of the resulting ubiquitin conjugates reveals that this observed synergy reflects an increase in Mdm2 ubiquitination. This study also suggests that ubiquitination of Mdm2 and MdmX may not serve as a signal for degradation, as we show that each are capable of synthesizing non-lysine 48 polyubiquitin chains and, in fact, utilize multiple lysine linkages. Taken together, these findings suggest a more active role for MdmX in the Mdm2-MdmX-p53 regulatory network than has been proposed previously.
Similar articles
-
Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.Biochemistry. 2003 Mar 4;42(8):2291-9. doi: 10.1021/bi0271291. Biochemistry. 2003. PMID: 12600196
-
Critical contribution of the MDM2 acidic domain to p53 ubiquitination.Mol Cell Biol. 2003 Jul;23(14):4939-47. doi: 10.1128/MCB.23.14.4939-4947.2003. Mol Cell Biol. 2003. PMID: 12832479 Free PMC article.
-
MDM2 promotes ubiquitination and degradation of MDMX.Mol Cell Biol. 2003 Aug;23(15):5113-21. doi: 10.1128/MCB.23.15.5113-5121.2003. Mol Cell Biol. 2003. PMID: 12860999 Free PMC article.
-
p53 regulation: teamwork between RING domains of Mdm2 and MdmX.Cell Cycle. 2011 Dec 15;10(24):4225-9. doi: 10.4161/cc.10.24.18662. Epub 2011 Dec 15. Cell Cycle. 2011. PMID: 22134240 Review.
-
Regulation of p53: a collaboration between Mdm2 and Mdmx.Oncotarget. 2012 Mar;3(3):228-35. doi: 10.18632/oncotarget.443. Oncotarget. 2012. PMID: 22410433 Free PMC article. Review.
Cited by
-
Soft Tissue Sarcomas with Chromosomal Alterations in the 12q13-15 Region: Differential Diagnosis and Therapeutic Implications.Cancers (Basel). 2024 Jan 19;16(2):432. doi: 10.3390/cancers16020432. Cancers (Basel). 2024. PMID: 38275873 Free PMC article. Review.
-
Intra molecular interactions in the regulation of p53 pathway.Transl Cancer Res. 2016 Dec;5(6):639-649. doi: 10.21037/tcr.2016.09.23. Transl Cancer Res. 2016. PMID: 30613472 Free PMC article.
-
HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53.Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12009-14. doi: 10.1073/pnas.2030930100. Epub 2003 Sep 24. Proc Natl Acad Sci U S A. 2003. PMID: 14507994 Free PMC article.
-
Polyphenols as Antitumor Agents Targeting Key Players in Cancer-Driving Signaling Pathways.Front Pharmacol. 2021 Oct 20;12:710304. doi: 10.3389/fphar.2021.710304. eCollection 2021. Front Pharmacol. 2021. PMID: 34744708 Free PMC article. Review.
-
Estrogen receptor alpha (ERα/ESR1) mediates the p53-independent overexpression of MDM4/MDMX and MDM2 in human breast cancer.Oncotarget. 2016 Mar 29;7(13):16049-69. doi: 10.18632/oncotarget.7533. Oncotarget. 2016. PMID: 26909605 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous